FHIR IG analytics

Resources that use this resource

No resources found

Resources that this resource uses

No resources found

Narrative

Note: links and images are rebased to the (stated) source

Source1

{
  "resourceType": "Evidence",
  "id": "293986",
  "meta": {
    "versionId": "10",
    "lastUpdated": "2025-10-07T17:12:54.639Z",
    "profile": [
      "http://hl7.org/fhir/uv/ebm/StructureDefinition/intervention-only-evidence"
    ]
  },
  "language": "en",
  "text": {
    "status": "generated",
    "div": "<!-- snip (see above) -->"
  },
  "url": "https://fevir.net/resources/Evidence/293986",
  "identifier": [
    {
      "type": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/v2-0203",
            "code": "ACSN",
            "display": "Accession ID"
          }
        ],
        "text": "FEvIR Object Identifier"
      },
      "system": "https://fevir.net/FOI",
      "value": "293986",
      "assigner": {
        "display": "Computable Publishing LLC"
      }
    },
    {
      "type": {
        "text": "outcomeId"
      },
      "system": "https://app.magicapp.org/#/guidelines",
      "value": "313962"
    },
    {
      "type": {
        "text": "picoId"
      },
      "system": "https://app.magicapp.org/#/guidelines",
      "value": "85798"
    },
    {
      "type": {
        "text": "sectionId"
      },
      "system": "https://app.magicapp.org/#/guidelines",
      "value": "73215"
    }
  ],
  "name": "Diabetic_ketoacidosis_Intervention_Evidence_from_MAGICapp_313962",
  "title": "MAGIC-derived InterventionOnlyEvidence: Diabetic ketoacidosis in SGLT2 inhibitors Group in Adults with type 2 diabetes",
  "citeAs": "MAGIC-derived InterventionOnlyEvidence: Diabetic ketoacidosis in SGLT2 inhibitors Group in Adults with type 2 diabetes [Database Entry: FHIR Evidence Resource]. Contributors: Computable Publishing®: MAGIC-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 293986. Revised 2025-10-07. Available at: https://fevir.net/resources/Evidence/293986. Computable resource at: https://fevir.net/resources/Evidence/293986#json.",
  "status": "active",
  "author": [
    {
      "name": "Computable Publishing®: MAGIC-to-FEvIR Converter"
    }
  ],
  "publisher": "Computable Publishing LLC",
  "contact": [
    {
      "telecom": [
        {
          "system": "email",
          "value": "support@computablepublishing.com"
        }
      ]
    }
  ],
  "useContext": [
    {
      "code": {
        "system": "https://fevir.net/resources/CodeSystem/179423",
        "code": "evidence-communication",
        "display": "Evidence Communication"
      },
      "valueCodeableConcept": {
        "coding": [
          {
            "system": "https://fevir.net/resources/CodeSystem/179423",
            "code": "InterventionOnlyEvidence",
            "display": "InterventionOnlyEvidence"
          }
        ]
      }
    }
  ],
  "copyright": "https://creativecommons.org/licenses/by-nc-sa/4.0/",
  "relatesTo": [
    {
      "type": "part-of",
      "targetReference": {
        "type": "Composition",
        "identifier": {
          "type": {
            "text": "FEvIR Linking Identifier"
          },
          "system": "https://fevir.net/FLI",
          "value": "MAGIC-5288-j1Wqrn-conversion-report",
          "assigner": {
            "display": "Computable Publishing LLC"
          }
        },
        "display": "MAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes"
      }
    }
  ],
  "description": "This Evidence Resource is referenced in an example for the EBMonFHIR Implementation Guide.",
  "variableDefinition": [
    {
      "description": "Adults with type 2 diabetes -- SGLT2 inhibitors",
      "variableRole": "population",
      "observed": {
        "reference": "Group/236949",
        "type": "Group",
        "identifier": {
          "type": {
            "text": "FEvIR Linking Identifier"
          },
          "system": "https://fevir.net/FLI",
          "value": "MAGIC-5288-j1Wqrn-intervention-group-MAGIC-5288-j1Wqrn-intervention-85394-I-85798",
          "assigner": {
            "display": "Computable Publishing LLC"
          }
        },
        "display": "SGLT2 inhibitors Group in Adults with type 2 diabetes"
      }
    },
    {
      "description": "Diabetic ketoacidosis",
      "variableRole": "outcome",
      "observed": {
        "reference": "EvidenceVariable/236971",
        "type": "EvidenceVariable",
        "identifier": {
          "type": {
            "text": "FEvIR Linking Identifier"
          },
          "system": "https://fevir.net/FLI",
          "value": "MAGIC-5288-j1Wqrn-313962",
          "assigner": {
            "display": "Computable Publishing LLC"
          }
        },
        "display": "Diabetic ketoacidosis"
      }
    }
  ],
  "statistic": [
    {
      "description": "Risk 0.2%",
      "statisticType": {
        "coding": [
          {
            "system": "https://fevir.net/sevco",
            "code": "STATO:0000607",
            "display": "proportion"
          }
        ]
      },
      "quantity": {
        "value": 0.002
      }
    }
  ]
}